By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

Roche Holding said a drug combination including a new experimental breast-cancer treatment fell short of its primary ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its primary objective. The results of the clinical trial mark a setback for the ...